In February 2024, the Company closed a public offering raising $94.5 million of gross proceeds and also raised $21.1 million of gross proceeds from ATM sales in January 2024. The Company reported $127 million of cash, cash equivalents, and investments on hand as of February 2, 2024, providing projected cash runway of 3+ years through March 31, 2027.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on CRBP:
- One new option listing on March 6th
- Corbus Pharmaceuticals to Participate in the BMO Capital Markets Inaugural Obesity Summit
- Corbus Pharmaceuticals upgraded to Buy from Hold at Jefferies
- Corbus Pharmaceuticals appoints Smethurst as CMO
- Corbus Pharmaceuticals Announces Chief Scientific Officer Resignation
